Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Mammoth Biosciences, Inc.

News headline image
Mammoth Biosciences Advances Lead Candidate MB-111 Toward the Clinic with the Presentation of Preclinical Durability and Safety Data at American Heart Association Scientific Sessions 2026
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences to Present Preclinical Data on In Vivo Gene Editing of Skeletal Muscle in Non-Human Primates with an Ultracompact CRISPR System at ASGCT 2025
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences to Present at the 2023 Annual Meeting of the American Society of Gene and Cell Therapy
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences Announces Appointment of Phil Tinmouth, Siang Chin to Key Leadership Roles
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences Named to Fast Company’s 2022 List of the Next Big Things in Tech
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences Named in BioSpace’s 2023 Best Places to Work
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test
From Mammoth Biosciences, Inc.
Via Business Wire
News headline image
Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology
From Mammoth Biosciences, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.